1. Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation.
- Author
-
Gianni C, Mohanty S, Di Biase L, Metz T, Trivedi C, Gökoğlan Y, Güneş MF, Bai R, Al-Ahmad A, Burkhardt JD, Gallinghouse GJ, Horton RP, Hranitzky PM, Sanchez JE, Halbfaß P, Müller P, Schade A, Deneke T, Tomassoni GF, and Natale A
- Subjects
- Atrial Fibrillation diagnosis, Atrial Fibrillation physiopathology, Equipment Design, Europe epidemiology, Female, Follow-Up Studies, Heart Conduction System physiopathology, Humans, Incidence, Male, Middle Aged, Postoperative Complications diagnosis, Prospective Studies, Time Factors, Treatment Outcome, United States epidemiology, Atrial Fibrillation surgery, Body Surface Potential Mapping, Catheter Ablation instrumentation, Heart Conduction System surgery, Imaging, Three-Dimensional, Postoperative Complications epidemiology
- Abstract
Background: Focal impulse and rotor modulation (FIRM)-guided ablation targets sites that are thought to sustain atrial fibrillation (AF)., Objective: The purpose of this study was to evaluate the acute and mid-term outcomes of FIRM-guided only ablation in patients with nonparoxysmal AF., Methods: We prospectively enrolled patients with persistent and long-standing persistent (LSP) AF at three centers to undergo FIRM-guided only ablation. We evaluated acute procedural success (defined as AF termination, organization, or ≥10% slowing), safety (incidence of periprocedural complications), and long-term success (single-procedure freedom from atrial tachycardia [AT]/AF off antiarrhythmic drugs [AAD] after a 2-month blanking period)., Results: Twenty-nine patients with persistent (N = 20) and LSP (N = 9) AF underwent FIRM mapping. Rotors were presents in all patients, with a mean of 4 ± 1.2 per patient (62% were left atrial); 1 focal impulse was identified. All sources were successfully ablated, and overall acute success rate was 41% (0 AF termination, 2 AF slowing, 10 AF organization). There were no major procedure-related adverse events. After a mean 5.7 months of follow-up, single-procedure freedom from AT/AF without AADs was 17%., Conclusion: In nonparoxysmal AF patients, targeted ablation of FIRM-identified rotors is not effective in obtaining AF termination, organization, or slowing during the procedure. After mid-term follow-up, the strategy of ablating FIRM-identified rotors alone did not prevent recurrence from AT/AF., (Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF